Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

STEP 1: FIRST AID > Biochem > Flashcards

Biochem Flashcards

1
Q

Osteogenesis imperfecta

A

Multiple fracture, blue sclerae, hearing loss, dental
Abn type I collagen
Problem in triple helix formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Ehlers Danlos

A

Type I or V collagen

Problem in collagen fibrils cross linking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Alport

A

Progressive nephritis, deafness, ocular distubance
X linked
Type IV collagen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Elastin

A

Rich in proline, glycine in nonhydroxylated form
Tropolastin with fibrillin scaffolding
Cross linking extracellulalry
If mutated, Marfan (fibrillin defect)

Wrinkles of aging due to reduced collagen/elastin production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Imprinting and diseases

A

Both Prader Willi and Angelman’s in chromosome 15
P= paternal allele not expressed
M=maternal allele not expressed

Prader: mental retard, hyperphagia, obesity, hypogonadism hypotonia
Angelman: mental retard, seizure, ataxia, inappropriate laughter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

X link dominant

A

Hypophosphatemic rickets:
vitamin D resistant rickets
Increased phosphate wasting at proximal tubule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mitochondrial myopathies

A

Rare disorders from mutations in mitochondria
Often presents with myopathy, CNS disease
Muscle Bx= ragged red fibers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Familial hypercholesterolemia

Hyperlipidemia type IIA

A

AD
Elevated LDL due to defective or absent LDL receptor
Homozygote >700+ mg/dl, hetero 300 mg/dl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hereditary hemorrhagic telangiectasia

Osler-Weber-Rendu syndrome

A

AD

Telangiectasia, recurrent epistaxis, skin discoloration, AVM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hereditary spherocytosis

A

AD
Spectrin, ankyrin defects
Hemolytic anemia, increased MCHC, splenectomy curative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Huntington

A

AD
Depression, prog dementia, choreiform movement, caudate atrophy, decreased GABA and ACH
Chromosome 4 (Hunting 4 food)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Marfan

A

AD
Subluxation of lenses
Long extremities
aortic incompetence and dissecting aortic aneurysm, floppy mitral valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MEN

A

AD

MEN2A and 2B due to ret gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

NF type 1

A

AD
Cafe au lait spot, neural tumor, lisch nodules (pigmented iris hamartomas)
Chromosome 17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Tuberous sclerosis

A 
AD
Facial lesions (adenoma sebaceum), hypopigmented ash leaf spots on skin, cortical and retinal hamartomas, seizures, mental retardation, renal cyst, renal angiomyolipomas, cardiac rhabdomyomas

Increased incidence of astrocytomas
Incomplete penetrance, variable presentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

VHL disease

A

AD
hemangioblastoma of retina, cerebellum, medulla
Major develop multiple bilateral RCC and other tumors
Constituitive expression of HIF, activation of angiogenic GF
Chromosome 3 (VHL=three letters)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Autosomal recessive

A

Albinism, ARPKD (formerly known as infantile, vs ADPKA=AD), CF, glycogen storage, hemochromatosis, mucopolysacchridoses (except for Hunter’s= XL), phenylketonuria, sickle, sphingolipidoses (except Fabry’s), thalassemias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

X linked

A

Bruton’s agammaglobulinemia, Wiskott-Aldrich, Fabry’s, G6PD, Ocular albinism, Lesch-Nyhan, Duchenne’s (and Becker’s), Hemophilia A&B, Fragile X, Hunter’s, Ornithine transcarbamoylase deficiency

Be Wise, Fool’s GOLD Heed’s False HOpe.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Duchenne’s and Becker’s

A

X-linked frameshift

Pseudohypertrophy of calf muscle due to fibrofatty replacement of muscles, cardiac myopathy

Use of Gower’s manuver
Duchenne onset before 5 yrs, Becker’s in adolescence

Dx= muscular Bx with muscular dystrophy with increased CPK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Fragile X syndrome

A

X linked, affecting methylation and expression of FMR1
2nd most common cause of genetic mental retardation

Enlarged testes, long face with a large jaw, large everted ears, autism, mitral prolapse

Fragile X= eXtra large testes, jaws and ears

Trinucleotide repeat CGG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Trinucleotide repeat expansion disease

A

Fragile X (CGG)
Friedreich’s ataxia (GAA)
Huntington’s (CAG)
Myotonic dystrophy (CTG)

X-Girlfriend’s First Aid helped Ace my Test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Down syndrome

A

Flat faces, epicanthal fold, simian crease, gap between 1st two toes, duodenal atresia

Ostinum primum type ASD
Most common cause of genetic mental retardation

Results of pregnancy Quad screen
Low AFP, high bHCg, low estriol, high inhibin A
US shows high nuchal in 1st trimster translucency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Edwards’ syndrome

A

Election age 18,
Low set EARS, clenched hands, small jaw, prominent occiput, severe mental retardation, rocker-bottom feet, congenital heart disease.
Death within 1 yr of birth

Results of pregnancy Quad screen
Low AFP, low bHCg, low estriol, normal inhibin A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Patau’s syndrome

A

Puberty at 13
Small eyes, small head,
holoProsencephaly, cleft liP/Palate, Polydactylyl
Severe mental retardation, rocker-bottom feet

Results of pregnancy Quad screen
low free bHCg, low PAPP-A, high nuchal translucency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Cri-du-chat

A

microdeletion of short arm of Cr 5

small head, moderate to severe mental retardation, high pitched mewing, epicanthal fold, cardiac (VSD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Williams

A

microdeletion of long arm of Ch 7 (deleted include elastin)

Elfin facies, intellectual diability, hypercalcemia (increase sensitivity to vitD), well developed verbal skills, extreme friendliness with strangers, CV problems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

22q11

A

microdeletion at Ch 22q11

Cleft palate, Abnormal facies, Thymic asplasia, Cardiac defect, Hypocalcemia 2/2 parathyroid aplasia

DiGeroge=thymic, parathyroid, cardiac
Velocardiofacial=palate, facial, cardiac

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Ethanol metabolism

A

NAD+ is the limiting agent
Zero order

Ethanol hypoglycemia: high NADH/NAD+ in liver, causing diversion of pyruvate to lactate and OAA to malate, thus inhibiting gluconeogenesis and stimulating FA synthesis.

1) Overproduction of lactate => acidosis
2) Depletion of OAA => shuts down TCA, shunting acetyl CoA into ketone production.
3) Breakdown of excess malate => increase NADPH and thus FA synthesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Malnutrition

A

Kwashiokor: protein malnutrition; skin lesion, edema, liver malfunction (fatty change due to low apolipoprotein). Small child with swollen belly
Malnutrition, Edema, Anemia, Liver (fatty)

Marasmus: energy malnutrition; tissue and muscle wasting, loss of subQ fat, and variable edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Metabolism sites

A

Cytoplasm: glycolysis, FA synthesis, HMP shunt, protein/steroid/cholesterol synthesis

Mito: beta oxidation, acetyl CoA production, TCA, oxidative phosphorylation

Both: heme synthesis, urea synthesis, gluconeogenesis
(HUGs take two)

31
Q

ATP production per glucose

A

Heart and liver: 32 via malate-asparate shuttle
Muscle: 30 via glycerol-3-phosphate shuttle
Anaerobic: 2 net ATP

32
Q

Hexokinase vs. glucokinase

A

Hexo: ubiquitous, high affinity (low Km), low capacity (low Vmax), uninduced by insulin, inhibited by glucose-6-P

Glucokinase: liver and beta cell only, low affinity (high Km), high capacity (high Vmax), induced by insulin, inhibited by fructose-6-P

At low glucose concentration, hexokinase sequesters glucose in tissue. At high glucose concentration, excess glucose store din the liver

33
Q

NADPH

A

Anabolic process, respiratory burst, P450, glutathione reductase.

34
Q

Regulation by F2,6BP

A

F2,6BP is a sub product of glycolysis from F6P, that activates PKF1 (from F6P to F1,6BP) to induce more glycolysis

FBPase2 and PFK2 are part of the same complex but respond in opposite manners to phosphorylation by protein kinase A

FBPase2=> converts F2,6BP back to F6P (more gluconeogenesis)
PFK2 => converts F6P to F2,6BP (more glycolysis)

Fasting: high glucagon -> high cAMP -> high protein kinase A -> high FBPase2, low PFK-2, less glycolysis
Fed: high insulin -> low cAMP -> low protein kinase A -> low FBPase 2, high PFK2, more glycolysis

35
Q

Pyruvate dehydrogenase complex

A

Pyruvate + NAD + CoA = Acetyl CoA, Co2, NAHD
Three enzymes with 5 cofactors:
B1, B2, B3, B5, lipoic acid

Activated by exercise: high NAD/NADH, high ADP, high Ca2+

This complex is similar to alpha ketoglutarate (same cofactors, similar substrate and action), which converts alpha ketoglutarate to succinyl CoA (TCA)

36
Q

Arsenic poisoning

A

Inhibit lipoic acid (thus inhibit pyruvate dehydrogenase complex)
Finding: vomiting, rice water stools, garlic breath

37
Q

Pyruvate dehydrogenase complex deficiency

A

Backup of substrates (pyruvate and alanine), resulting in lactic acidosis

Most causes due to X linked mutation for E1-alpha (subunit for PDC).
Finding: neurologic deficit, starting in infancy.

Treatment: increase intake of ketogenic nutrients
Lysine and leucine (onLy pureLy ketogenic AA)

38
Q

Pyruvate metabolism

A

1) Alanine aminotransferase : Cahill cycle, carrying AA from muscle to liver
2) Puryvate carboxylase (biotin): OAA can replenish TCA cycle or be used in gluconeogenesis
3) Pyruvate dehydrogenase (B1,2,3,5, lipoic acid): transition from glycolysis to TCA
4) Lactic acid dehydroganse (B3): end of anerobic acid (major pathway in RBC, leukocytes, kidney medulla, lens, testes, and cornea)

39
Q

TCA cycle

A

Products: 3NADH, 1FADH2, 2CO2, 1GTP per acetyl CoA
thus 10 ATP/acetylCoA (2x everything per glucose)

Alpha ketoglutarate dehydrogenase complex requires the same cofactors as the pyruvate dehydrogenase complex (B1,2,3,5, lipoic acid)

Citrate Is Kreb’s Starting Substrate For Making OAA.

40
Q

Oxidative phosphorylation

A

NADH from electrons enter via malate-aspartate(cardiac/liver) and glycoerol-3-phosphate(muscle) shuttle. FADH2 transfer to complex II
1NADH -> 3ATP, 1FADH2 ->ATP

Electron transport inhibitors: rotenone, cyanide, antimycin A, CO
ATP synthase inhibitor: oligomycin
Uncoupling agent: 2,4-DNP, aspiring, thermogenin

41
Q

Gluconeogenesis irreversible enzymes

A

Pathway Produces Fresh Glucose
1) pyruvate carboxylase (mito); pyruvate to OAA
= requires biotin, ATP, activated acetyl CoA
2) PEP carboxykinase (cyto): OAA to PEP
= requires GTP
3) F1,6BP (cyto): F1,6P to F6P
4) Glucose-6-Phosphatase (ER): glucose-6-p to glucose

Odd chain FA yield propionyl-CoA, which can enter TCA as succinyl CoA, undergoes gluconeogenesis, and serves as glucose source.

However, even chain FAT cannot produce new glucose, since they yield only acetyl-CoA equivalents.

42
Q

HMP shunt (pentose phosphate pathway)

A

Provide a source of NADPH from an abundantly available glucose-6-phosphate.

Also yields ribose for nucleotide synthesis and glycolytic intermediates.

Two phases: oxidative vs. non oxidative, both occur in cytoplasm. No ATP produced.

Sites: lactating mammary glands, liver, adrenal cortex (site of fatty acid or steroid synthesis), RBC

Oxidative (irreversible): Glucose-6-P to 2NADPH, ribulose-5-Pi, CO2 by glucose-6-p dehydrogenase

Non oxidative (reversible): ribulose-5-P1 to ribose-5-P1, G3P, F6P by phosphopentose isomerase and transketolases (require B1)

G6PD: converts NADP+ to NADPH from G6P (becomes 6PG).

43
Q

G6PD deficiency

A

X-linked
NADPH required to keep glutathione reduced.

Reduced NADPH in RBC leads to hemolytic anemia due to poor RBC defense against oxidizing agents
such as fava, sulfonamides, primaquines, antiTB drugs.
Infection can also precipitate hemolysis via free radical generation.

Heinz body and Bite cells
Increased malarial resistance

44
Q

Essential fructosuria

A

AR, fructokinase deficiency (1st step).
Benign, asymptomatic, since fructose not trapped in cell
Symtpoms: fructose in blood and urine
This is milder than analogous disorders of galactose

45
Q

Fructose intolerance

A

AR, aldolase B deficiency (2nd step).
Fructose-1-phosphate accumulates, causing a decrease in available phosphate, thus inhibiting glycogenolysis and gluconeogenesis.

Symptoms: hypoglycemia, jaundice, cirrhosis, vomiting.
Treatment: reduced intake of fructose.

Fructose bypasses RLS of glycolysis (PFK) via this pathway.

46
Q

Galactokinase deficiency

A 
AR, galactokinase deficiency (1st step)
Galactitol accumulates (via aldose reductase) if galactose is present.
Symptoms: relatively mild, galactose in blood and urine, infantile cataracts

May initially present as failure to tract objects or develop a social smile.

47
Q

Classic galactosemia

A

AR, galactose-1-phosphate uridyltransferase deficiency (2nd step). (from galactose-1-p to gluclose-1-P)

Accumulation of toxic substances, galactitol.

Symptoms: FTT, jaundice, hepatomegaly, infantile cataract, mental retardation.
Treatment: exclude galactose and lactose from diet.

Fructose is to Aldolase B as Galactose is to UridylTransferase (FAB GUT)

48
Q

Sorbitol

A

Liver, lens, ovaries, seminal vesicles have both enzymes:
Glucose to sorbitol (aldose reductase + NADPH)
Sorbitol to fructose (sorbitol dehydrogenase + NAD+)

Schwann, retina, kidney only one enzyme
Glucose to sorbitol (aldose reductase + NADPH)

Thus osmotic damage leading to cataracts, retinopathy, and peripheral neuropathy in DM.

49
Q

Amino acids

A

Essential;
Glucogenic: met, val, his
Glucogenic/keto: ile, phe, thr, trp
Keto: leu, lys

Acidic: asp, glu (negatively charged at body pH)
Basic: arg, lys, his (arg most basic, his no charge)

50
Q

Urea cycle

A

AA catabolism generates common metabolites (pyruvate, acetyl-CoA), which serve as metabolic fuels.

Excess nitrogen (NH4) generated is converted to urea, and excreted by the kidney

RLS: carbamoyl phosphate synthetase 1 (in cyto, the rest in mitochondria).

Carbomyol phosphate + ornithine -> citrullin -> argininosuccinate -> fumarate (out) and arginine -> urea (out) and ornithine (recycled)

51
Q

AA transport by alanine and glutamate

A

Muscle;
AA (NH3) to alpha ketoacid, alpha ketoglutarate to glutamate (NH3)
pyruvate to alanine (NH3) (Alanine cycle, transported to liver).

pyruvate initially enters as glucose, then produces alanine and lactate, which get transported to liver (Cori cycle).

“Alan and his lactate leave the muscle”

52
Q

Hyperammonemia

A

Excess NH4+, which depletes alpha ketoglutarate, leading to inhibtion of TCA.
Treatment: limit protein i diet. Benzoate or phenylbutyrate (which bind to AA and lead to excretion) may be given to reduced ammonia levels.

Lactulose acidify the GI tract, and trap NH4+ for excretion.

Ammonia intoxication: tremor, slurring of speech, somnolence, vomiting, cerebral edema, blurring of vision.

53
Q

Ornithine transcarbamoylase deficiency

A

Most common urea disorder, X linked (HOpe)
Interferes with the body’s ability to eliminate ammonia, excess carbamoyl phosphate is converted to orotic acid (part of pyrimidine synthesis pathway)

Finding: increased orotic acid in blood and urine, decreased BUN, and symptoms of hyperammonemia.

54
Q

Phenylketouria

A

AR. Decreased pheylalanine hydroxylase or decreased tetrahydrobiopterin cofactor (malignant phenylketonuria)

Tyrosine becomes ESSENTIAL.

Increased phenylalanine leads to excess phenylketones in urine. (phenylacetate, phenyllactate, phenylpyruvate).

Finding: mental retardation, growth retardation, seizures, fair skin, eczema, musty body order.

Treatment: reduce phenylalanine, increase tyrosine in diet.

Maternal PKU: microcephaly, mental retardation, growth retardation, congenital heart defects.

55
Q

Alkaptonuria: ochronosis

A

AR. Homogentisic acid oxidase deficiency, pathway of tyrosine to fumarate. Benign disease

Finding: dark connective tissue, brown pigmented sclera, urine gets OXIDIZED and turns black on prolonged exposure.

May habe debilitating arthralgias (homogentisic acid toxic to cartilage).

56
Q

Albinism

A

Congenital deficiency of either of the following

1) tyrosinase (can’t synthesize melanin from tyrosine)= AR
2) tyrosine transporter (decreased tyrosine so melanin)

Can result from a lack of migration of neural crest cells.

Variable inheritance due to locus heterogeneity
(vs. ocular albinism, X-linked).

57
Q

Homocystinuria

A

Homocysteine + serine => cysthionine (cystathionine synthase/B6)

Homocysteine => methionine (homocysteine methyltransferase/B12)

Three forms. All three AR
1) Cystathionine synthase deficiency
= treat with low Met, high Cys, and high B9, B12 in diet
2) Decreased affinity of cystathionine synthase for pyridoxal phosphate
= treat with increased vitamin B6 in diet
3) Homocysteine methyltransferase (require B12)

All forms result in excess homocystine, cysteine becomes essential

Finding: high homocystein in urine, mental retardation, osteoporosis, tall stature, kyphosis, lens subluxation (downward and inward vs Marfan), and atherosclerosis (stroke/MI)

58
Q

Cystinuria

A

AR, Renal tubular AA transporter for cysteine, ornithine, lysine and arginine in the PCT

Excess cystine in the urine can lead to precipitation of hexagonal crystals and renal staghorn calculi.

Treat with good hydration and urinary alkalinzation.

(cystine is made of two cysteines connected by disulfide)

59
Q

Maple syrup urine disease

A

AR. Blocked degradation of branched AA (ile, leu, val)
Due to reduced alpha ketoacid dehydrogenase (B1)
Causes increased alpha ketoacid in the blood, esp leu.

Symptoms: severe CNS defects, mental retardation, death.
Urine smells like maple syrup.

I Love Vermont maple syrup from maple trees with branches.

60
Q

Hartnup disease

A

AR, defective neutral AA transporter on renal and intestinal epithelial cells.
Causes tryptophan excretion in urine and decreased absorption from the gut.

Leads to pellagra (B3), imagine three indian guys

61
Q

Glycogen regulation

A

Glucagon/EP induces adenylyl cyclase (up cAMP), high cAMP activates protein kinase A, which activates glycogen phosphorylase kinase, which activates glycogen phosphorylase to release glucose.

Insulin activates protein phosphatase, which inactivate both glycogen phosphorylase kinase AND glycogen phosphorylase.

Ca2+/calmodulin in muscle activates phosphorylase kinase so that glycogenolysis is coordinated with muscle activity.

62
Q

Glycogen

A

Branches have alpha (1,6), linkages have alpha (1,4)

Skeletal: glycogen undergoes glycogenolysis -> glucose-1-phosphate -> glucose-6-phosphate, which is rapidly metabolized during exercise.

Hepatocyte: glycogen is stored and undergoes glycogenolysis to maintain blood sugar at appropriate levels.

Note: a small amount of glycogen is degraded in lysosomes by alpha 1,4 glucosidase.

63
Q

Fatty acid metabolism

A

FA degradation occurs where its products will be consumed (in the mito).

Carnitine deficiency: inability to transport LCFA into the mitochondria, resulting in toxic accumulation.
Symptoms: weakness, hypotonia, and hypoketotic hypoglycemia.

Acyl-CoA dehydrogenase deficiency: increased dicarboxylic acid, decreased glucose and ketones.

Sytrate= SYnthesis, citrate shuttle (ATP citrate lyase produces acetyl CoA)
CARnitine=CARnage (large killing) of fatty acid, carnitine shuttle (fatty acid CoA synthetase produces acyl CoA)

64
Q

Ketone bodies

A

In the liver, FA and AA are metabolized to acetoacetate and beta hydroxybutyrate (to be used in muscle/brain).

1) In prolonged starvation and DKA, OAA is depleted for gluconeogenesis.
2) In alcoholism, excess NADH shunts OAA to malate.

Both processes stall the TCA cycle, which shunts glucose and FFA toward the production of ketone bodies.

Made from HMG-CoA. Metabolized by the brain to molecules of acetylCoA. Excreted in the urine.

65
Q

Fasting and starvation

A

Fed state: glycolysis and aerobic respiration
Fasting: hepatic glycogenolysis > hepatic gluconeogenesis/adipose releases FFA.

Starvation 1-3 days: hepatic glycogenolysis, adipose release of FFA, muscle and liver which shift fuel use from glucose to FFA, hepatic gluconeogeneis from peripheral tissue lactate and alanine, and from adipose tissue glycerol and propionyl CoA(only from odd chain FFA, the only triacylglycerol components that contribute to gluconeogenesis).

  • Glycogen reserves depleted after day 1.
  • RBC lacks mitochondria so cannot use ketones.

Starvation after 3 days: adipose stores (ketone bodies become the main source of energy for the brain and heart). After that, vital protein degradation.
*Amount of adipose stores determines survival time.

1g protein/carb =4 kcal
1g fat = 9kcal

66
Q

Cholesterol synthesis

A

RLS is catalyzed by HMG-CoA reductase, which converts HMG-CoA to mevalonate.

2/3 of plasma cholesterol is esterified by lecithin-cholesterol acyltransferase LCAT.

Nascent HDL uses LCAT to catalyzed esterification of cholesterol, then become mature HDL.

Mature HDL uses cholesterol ester transfer protein (CETP) to mediate transfer of cholesterol esters to other lipoprotein particles.

67
Q

Familial dyslipidemia

1-hyperchylomicronemia

A

AR,
Lipoprotein lipase deficiency or altered apolipoprotein C-II.
Cause pancreatitis, hepatosplenomegaly, and eruptive/pruritis xanthomas (no increased risk for atherosclerosis).

Increased blood level: chylomicrons, TG, cholesterol

68
Q

Familial dyslipidemia

2a-familial hypercholesterolemia

A

AUTOSOMAL DOMINANT
Absent or reduced LDL receptors.
Causes acccelerated atherosclerosis, tendon xanthomas, and corneal arcus.

Increased blood level: LDL, cholesterol

69
Q

Familial dyslipidemia

IV-hyper-triglyceridemia

A

AUTOSOMAL DOMINANT
Hepatic overproduction of VLDL, causes pancreatitis

Increased blood level: VLDL, TG

70
Q

Abetalipoproteinemia

A

AR, mutation if microsomal triglyceride transfer protein (MTP) gene
Decreased B-48, B-100 => decreased chylomicron and VLDL synthesis and secretion.

Symptoms appear in the first few months of life. Intestinal Bx show lipid accumulation within enterocytes due to inability to absorbed lipid as chylomicrons.

Findings: FTT, steatorrhea, acanthocytosis, ataxia, night blindness.

71
Q

Lipoprotein functions

A

Chylomicrons: delivers TG to peripheral tissues, delivers cholesterol to liver in the form of chylomicron remnants (mostly depleted of their triacylglycerol). Secreted by intestinal epithelial cells

VLDL: delivers dietary TG to peripheral tissue, secreted by liver.

IDL: formed in the degradation of VLDL, delivers TG and cholesterol to liver.

LDL: delivers hepatic cholesterol to peripheral tissues. Formed by hepatic lipase modifcation of IDL in the peripheral tissue. Taken up by target cells via receptor mediated endocytosis.

HDL: mediates reverse cholesterol transport from periphery to liver. Acts as a repository for apoC and apoE, which are needed for chylomicron and VLDL metabolism. Secreted from both liver and intestine..

72
Q

Major apolipoproteins

A

E: mediates remnants reuptake: chylo, CR, VLDL, IDL, HDL
(Only LDL lacks E)

A-1: activates LCAT, only in HDL

C-II: (c for cofactor) Lipoprtein lipase cofactor: chylo, VDLD, HDL.

B-48: mediates chylo secretion: chylo and CR

B-100: binds LDL receptor: VLDL, IDL, LDL

73
Q

Urea cycle

A

Ordinarily, careless crappers are also frivolous about urination

Ornithine + carbamonyl phosphate (by OTC) => citrullin (+aspartate) => argininosuccinate => arginine (fumarate out) => urea and ornithine

Carbamonyl phosphate synthesized by carbamoyl phosphate synthetase I with N acetyl glutamate cofactor

74
Q

N acetylglutamate deficiency

A

Required cofactor for carbamoyl phsophate synthetase I
Absence of N acetylglutamate => hyperammonemia

Presentation identifcal to carbamoyl phosphate synthetase I deficiency.
However increased ornithine with normal urea cycle enzymes suggest hereditary N acetylglutamate deficiency.

STEP 1: FIRST AID (13 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions